Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001556263-18-000001
Filing Date
2018-01-17
Accepted
2018-01-17 16:13:48
Documents
1
Effectiveness Date
2018-01-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15300
  Complete submission text file 0001556263-18-000001.txt   16524
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-303459 | Film No.: 18531631
SIC: 2834 Pharmaceutical Preparations